[HTML][HTML] COVID-19 therapeutics: an update on effective treatments against infection with SARS-CoV-2 variants

BT Padasas, E Españo, SH Kim, Y Song, CK Lee… - Immune …, 2023 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic is one of the most
consequential global health crises in over a century. Since its discovery in 2019, severe …

Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments

P Goodarzi, F Mahdavi, R Mirzaei, H Hasanvand… - International …, 2020 - Elsevier
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …

[HTML][HTML] The development of COVID-19 treatment

Y Yuan, B Jiao, L Qu, D Yang, R Liu - Frontiers in immunology, 2023 - frontiersin.org
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest …

Molecular and clinical aspects of COVID-19 vaccines and other therapeutic interventions apropos emerging variants of concern

KU Islam, TME A-Elgadir, S Afaq, T Ahmad… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) has overwhelmed the healthcare and economy of
the world, with emerging new variants of severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] COVID-19 antiviral and treatment candidates: current status

E Españo, D Kim, J Kim, SK Park, JK Kim - Immune network, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 has severely impacted global health and economy …

Treatments for COVID-19: Lessons from 2020 and new therapeutic options

F Salasc, T Lahlali, E Laurent, M Rosa-Calatrava… - Current Opinion in …, 2022 - Elsevier
To face the COVID-19 pandemic, prophylactic vaccines have been developed in record
time, but vaccine coverage is still limited, accessibility is not equitable worldwide, and the …

[HTML][HTML] Therapeutics for COVID-19 and post COVID-19 complications: An update

D Basu, VP Chavda, AA Mehta - Current Research in Pharmacology and …, 2022 - Elsevier
Since its inception in late December 2020 in China, novel coronavirus has affected the
global socio-economic aspect. Currently, the world is seeking safe and effective treatment …

SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines

X Li, Z Mi, Z Liu, P Rong - Frontiers in Microbiology, 2024 - frontiersin.org
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), emerged in December 2019 with staggering economic fallout …

Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies

YW Zhou, Y Xie, LS Tang, D Pu, YJ Zhu… - Signal transduction and …, 2021 - nature.com
Owing to the limitations of the present efforts on drug discovery against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the lack of the understanding of the …

A comprehensive review of COVID-19 virology, vaccines, variants, and therapeutics

L Forchette, W Sebastian, T Liu - Current medical science, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of
the coronavirus disease 2019 (COVID-19), has caused more than 179 million infections and …